India, June 17 -- As global demand for AI-driven healthcare innovation surges-with the $1.7 billion AI in drug discovery market in 2024 expected to increase more than quadruple to $8.5 billion by 2030 (CAGR ~30%)-India is developing into the strategic center for this shift. Nowhere is this more evident than at ZS, where India is home to nearly 70% of the global workforce and their fastest adoption of pioneering AI in drug discovery, digital health, and capability centers.

India currently has more than 1,700 Global Capability Centres (GCCs)-with approximately 1.9 million professionals and generating more than $64 billion in exports-as GCCs are evolving from a delivery service focus to innovation engines.

In this timely Q&A, Mohit Sood, t...